|
||||||||||
| Dear Colleagues， 尊敬的同仁， 随着移动互联网技术和社交网络的兴起，人们接受信息的渠道越来越多，时间也越来越碎片化。微博、微信、小视频、朋友圈分享、H5、论坛、贴吧等，每个人每天一睁眼就被巨量的信息所包围。渠道越来越多，也意味着内容更加灵活，手段更加多样化，也意味着更复杂、更难操控。 With the rise of Internet technologies and social networks, there are more channels to receive information and time is also get fragmented. Everyone is surrounded by huge amounts of information every day via Weibo, WeChat, small videos, H5, forums, post bars and so on. The growing number of medial channels means more flexible content and a more diversified communication means, which cause the information are more difficult to manipulate due to its complexity. 自媒体时代的到来，将品牌商置于一个尴尬的境地，哪一个传播推广模式是最适合自己的，在制定传播策略之前，如何对各个渠道做最有效的评估，是摆在各行业品牌主不得不面对的一个问题。 With the coming of We-media era ，brand owners have been placed in an embarrassing situation. They will have to consider and choose appropriate promotion model and evaluate information channels before making media communications strategy. 医药行业目前营销重点还在传统媒体上，如何在自媒体时代的资讯蓝海中脱颖而出，进行的数字化推广，诺华制药在这方面进行了积极的探索。此次2018中国营销技术与数字化创新峰会（10月24-25，上海）很荣幸的请到了诺华公司高血压事业部全国市场总监余锦毅先生，以“碎片化和自媒体传播推广模式在医药行业的应用“为主题，分享诺华在自媒体时代的数字化推广经验。 Currently, the pharmaceuticals industry are still focus on traditional media for marketing. Novartis have been actively explore ways to stand out and make digitized promotion in the We-media era.China Martech and Digital Innovation Summit 2018（Oct. 24th-25th，Shanghai） was honored to invite Mr. Jinyi Yu, National Marketing Director of Novartis's Hypertension Division, to share us with the theme of “fragmentation and We-media communication promotion model in the pharmaceutical industry”.
|
